There are 119 resources available
1P - Sitravatinib + Tislelizumab in Patients with Anti-PD-(L)1 Refractory/Resistant Metastatic Non-small Cell Lung Cancer (NSCLC)
Presenter: No Gao
Session: e-Poster Display session
2P - Sitravatinib + Tislelizumab in Patients with Metastatic Non-small Cell Lung Cancer (NSCLC)
Presenter: Zhou Qing
Session: e-Poster Display session
3P - Targeting pancreatic adenocarcinoma upregulated factor (PAUF) to treat pancreatic cancer (PC): In vivo efficacy and safety of PBP1510, a first in class monoclonal antibody (mAb)
Presenter: Sumita Pradhan
Session: e-Poster Display session
4P - Antitumor efficacy of integrin _V_3 Antibody conjugated ZnO Nanocarrier based Drug Delivery System to target Breast carcinoma
Presenter: Karuppaiya Vimala
Session: e-Poster Display session
8P - Pharmacokinetic (PK) profile and food effect of RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase in patients (pts) with cancer
Presenter: Stephanie Lheureux
Session: e-Poster Display session
9P - Preliminary population pharmacokinetic (popPK) co-variates and exposure response (ER) assessment of QT for RP-3500, a highly potent and specific inhibitor of ataxia telangiectasia and Rad3-related (ATR) protein kinase
Presenter: Elizabeth Lee
Session: e-Poster Display session
50P - Targeting the renin-angiotensin system in gastric cancer therapeutics
Presenter: Surenjav Chimed
Session: e-Poster Display session
51P - Mitochondrial Pro-Apoptotic Properties of isolated compounds from two soft corals of Persian Gulf
Presenter: afsaneh yegdaneh
Session: e-Poster Display session
52P - Novel inhibitors of androgen receptor with antiproliferative potency against hormone-sensitive and hormone-resistant breast cancer cells
Presenter: Alexander Scherbakov
Session: e-Poster Display session
53P - Assessing the reporting quality of early phase dose-finding trials
Presenter: Christina Yap
Session: e-Poster Display session